Miller-Rich Nancy 4
4 · Aldeyra Therapeutics, Inc. · Filed Jun 6, 2024
Insider Transaction Report
Form 4
Miller-Rich Nancy
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-04+1,736→ 1,736 totalExercise: $4.09Exp: 2034-06-03→ Common Stock (1,736 underlying) - Award
Stock Option (Right to Buy)
2024-06-04+40,282→ 40,282 totalExercise: $4.09Exp: 2034-06-03→ Common Stock (40,282 underlying)
Footnotes (2)
- [F1]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.
- [F2]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation Committee of the Board of Directors of the Issuer through the applicable vesting date.